Reflecting on the emergence of N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide methanesulfonate, it holds up a mirror to how research culture shapes the landscape of synthetic compounds. Decades back, once people started tinkering with phenylmethanesulfonamides, it was the grit of organic chemists and rigorous pharmacologists that nudged the field forward. Scientific journals filled up with painstaking experiments on substitution patterns and refining synthetic routes. This compound’s story tracks the arc of analytical tools getting sharper, with chromatography and spectroscopy taking the guesswork out of purification and analysis. In my own grad school experience, I watched how improvements in isolation techniques let even younger researchers attempt what once seemed out of reach, giving more folks the chance to tackle complex targets like this one. Its development echoes the larger lesson of chemistry: incremental progress, never a miracle, rewards steady work and close observation.
The chemical may sound obscure, but its value shines through the different hats it wears. In pharmaceutical labs, this molecule’s backbone shows up in studies of adrenergic agonists, with teams zeroing in on its possible therapeutic effects. When I spent time in a drug discovery startup, compounds in this family often triggered debates on balancing pharmacological activity with off-target risks. Chemists and process engineers also study its salt forms, including methanesulfonate, for tuning solubility or biological compatibility. While newer entities grab headlines, the foundational understanding of these molecules gives drug designers a toolkit to manipulate absorption and stability. Realistically, this one won’t make splashy news, but it sits firmly in the toolkit of those who build tomorrow’s medicines.
Handling this compound reminds you how closely physical properties tie to everyday lab practices. Unlike volatile, smelly intermediates, this molecule usually turns up as a white crystalline powder with moderate solubility in water and common solvents. My experience with similar compounds confirms the importance of knowing melting points and hygroscopicity; nothing upends a reaction faster than underestimating clumping due to moisture uptake. The presence of both hydroxy and sulfonamide groups means it resists simple degradation, but strong bases or acids change that story. The physical profile lets formulation scientists create robust storage and delivery options, which helps in scaling applications beyond the benchtop.
The scientific community pays more attention to clear labeling and tight technical specs every year. Laboratories that take their data seriously carefully note purity thresholds—often above 98%—and test for trace byproducts by HPLC and NMR. As I’ve seen during audits, clear specs protect both research outcomes and user safety. Subtle mistakes in batch labeling can ripple from one experiment to another, so modern warehouses lean heavily on barcoding and electronic tracking of lot numbers. In regulated spaces, rigorous documentation remains one of the best defenses against unforced errors, anchoring trust in every bottle.
Synthesizing N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide methanesulfonate usually starts from precious phenyl rings and walks through protection and substitution steps with withering patience. Reductive amination and sulfonamide condensation may sound routine, but getting clean conversion still demands sharp technique. During my time shadowing organic chemists, I watched entire afternoons spent optimizing solvent choices and temperatures—a few degrees can flip selectivity, and that lesson sticks. The methanesulfonate salt is produced by neutralization with methanesulfonic acid, a step easy to describe but prone to surprises if purity slips. Good prep work saves headaches downstream and separates excellent labs from adequate ones.
The molecule opens doors to related chemistry, like N-alkylation or acylation of the sulfonamide moiety. Those who chase analog development and structure-activity relationships often reach for this backbone. One time, our group pushed a similar substrate through oxidations and reductions, trying to build out a cryoprotective scaffold. Every minor tweak altered how the compound performed, underlining that small changes ripple through biological systems. In the realm of medicinal chemistry, these modifications help map the difference between a promising tool compound and an unusable side product.
Depending on the context, this compound carries a roster of synonyms: from its IUPAC systematic name to shorter trade labels found cataloged by chemical suppliers. A single molecule wears different names in patent filings, academic papers, and safety sheets. I recall tracking down a reference compound only to discover three distinct synonyms in use, slowing down our orders. This messiness shows why researchers double-check every line in Material Safety Data Sheets and catalogs, since one typo flattens days of planning. Consistent nomenclature across jurisdictions might improve reliability, but institutional inertia makes progress slow.
Safe handling grows out of respect, not paranoia. In my lab years, the most serious accidents never announced themselves with dramatic fumes but with mundane spills or unlabeled vials. The hydroxy and amine functions in this compound demand gloves and adequate ventilation, owed in part to potential absorption or sensitization. Long stretches among chemical stocks taught me the value of daily safety checks; proper training trumps any warning label. Regulatory guides—such as OSHA in the US or REACH in Europe—anchor risk assessments used to craft protocols, and regular review keeps teams sharp. In recent years, groups focused on green chemistry and sustainability call for minimizing waste and seeking replacement reagents, so operational standards shift as knowledge grows.
N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide methanesulfonate has a fingerprint across multiple domains, despite its specialty vibe. Some research teams look to its adrenergic profile for cardiovascular or bronchodilator applications, hoping to tweak its action for therapeutic gain. Studies circle around its possible antimicrobial properties and as a scaffold for newer analogs. Colleagues in analytical chemistry note its use as a reference standard in chromatography method development. Industrial chemists sometimes adapt sulfonamide frameworks to catalysis and polymer science, sifting for ways to anchor new materials. The breadth of application underscores the molecule’s real value—a launchpad for innovation, limited only by imagination and funding.
Current R&D pushes this compound beyond the screens of pharmacology. The search for improved selectivity and fewer side effects motivates teams to modify its aromatic and aliphatic components. Postdoctoral fellows working through combinatorial libraries build out whole catalogs of derivatives, aiming for a better fit with drug targets. My own stint in collaboration-driven projects showed the importance of both open-access data and persistent hypothesis-testing. Researchers also try biodegradability studies, thinking ahead to environmental impact long before regulators insist. Success hinges on sharing findings, which builds a better map for the next set of experiments.
New compounds always bring questions about toxicity. Animal studies and cell-based assays work to box in both acute and chronic risks. Too many substances languished in development because of undiscovered hazards, a reminder that every promising candidate needs thorough screening. Toxicologists weigh not just direct harm, but metabolic byproducts and persistence in tissues. Even the most effective therapy can stumble if its breakdown products stick around or trigger off-target effects. Clear, published toxicity profiles based on honest data form the backbone of responsible science, saving both lives and livelihoods down the line.
Investigators realize that chemical innovation often pops up in unexpected corners. A molecule like this, with roots in earlier science, reveals fresh directions each time analytical methods advance or a new target comes into focus. Artificial intelligence changes how researchers predict activity, while green synthesis rethinks the environmental cost. As more is learned about human biology, especially at the receptor level, compounds once typed as niche may suddenly occupy the front row in drug discovery. Based on hard-won experience, growth comes not from hype but from patient, honest progress backed up by clear, shareable data.
N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide Methanesulfonate goes by a more familiar name in hospitals: epinephrine, specifically its methanesulfonate salt form. If you’ve ever visited an emergency department or sat in on CPR training, you’ve seen this compound in action. The story of this medication’s uses has roots in basic life support and deep branches into emergency medicine, respiratory therapy, and allergy care.
I’ve worked in clinics where someone started wheezing and swelling, turning red after an unknown trigger. The immediate call was for epinephrine—not later, not after some other measure failed, but right then. This medication steps in as a life-saver for anaphylaxis, a terrible allergic reaction that closes off the airway. The injection opens up airways, raises dangerously low blood pressure, and buys precious time while the underlying cause gets sorted out and other treatments line up. For those walking around with allergies to bee stings or peanuts, the idea of not having a dose available is unthinkable.
Asthma is another arena where this medication makes its mark. For patients in the throes of a severe attack, normal breathing can seem like a lost dream. Emergency use of N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide Methanesulfonate rapidly relaxes the bronchial muscles. Back in residency, I watched an asthmatic child go from gasping to calm in just a few minutes after an injection. That image never leaves you. While long-term asthma control uses other drugs, nothing matches the speed here in a pinch.
Struggling to restart a stopped heart means grabbing time and outcomes out of thin air. In cardiac arrest—think sudden collapse, no pulse—epinephrine acts as one of very few tools that might restart circulation. The guidelines from organizations like the American Heart Association support its dosing during cardiopulmonary resuscitation. The rush feels like it comes more from urgency than the medication, but statistics show that its early use can give people the shot at a second chance. Without medication support, survival rates after out-of-hospital cardiac arrest would be even bleaker.
Dentists and surgeons also rely on this compound in diluted form mixed with local anesthetics. Its role might seem small, but by constricting blood vessels, it keeps the numbing agent where it’s needed and reduces bleeding. As a patient, you might never know this ingredient shortened your dental procedure or cut down on post-op swelling and bruising.
Despite its huge importance, epinephrine does not come risk-free. It can raise blood pressure to dangerous levels and lead to heartbeat sensations or even arrhythmias. That’s why training, protocols, and ongoing research matter so much every time it gets pulled from the crash cart or EpiPen. Making sure this life-line remains available means securing supply chains, listening to people who rely on it, and continuing to teach both healthcare professionals and the public about proper use.
Reducing cost and improving access stand out as ongoing priorities. Across the world, there remains a gap between those who can carry or receive timely dosing and those who can’t. Pushing innovators to keep solutions affordable and building public awareness around the proper storage and use of these medications can close that gap. For thousands who rely on fast relief from asthma or face severe allergies every day, progress here means more lives saved and more outcomes turned in the right direction.
Clear dosage instructions save a lot of headaches, whether a product comes from a pharmacy or a natural food store. Ignoring those directions can turn something with health benefits into a source of side effects or wasted money. Every product works best within a safe range, and overdosing hardly ever delivers twice the results. On the flip side, skimping out often means missing any potential benefit.
Back in my early days managing a local wellness shop, customers walked in with bottles missing the most basic information: How much should I take? Some people would double the recommended amount hoping for faster results. Plenty would under-dose, convinced it kept things safer. In both cases, folks were flying blind. Over time, I realized that actual science, clinical evidence, and safety testing shape those guidelines printed on bottles—and every product follows a different story.
Doctors, pharmacists, and sometimes registered dietitians can explain what’s behind the label’s numbers. Their advice takes into account a person’s age, weight, and health conditions. For example, ibuprofen packages supply a standard dose for adults. Children use a lower dose, carefully measured by a small cup, not by guessing. Herbal teas and supplements often give scoop or dropper measurements. Each specific dose comes from research that determined the lowest amount that consistently works plus a safety margin.
Mixing medications and supplements without a second thought can lead to stomach upset, weakened effects, or more serious troubles. That’s why healthcare guidance really does make a difference, especially when using multiple products. The Food and Drug Administration keeps a close eye on proper labeling to reduce the risk of harm from confusion or overdose.
Directions aren’t just about how much, but how to use a product. Some tablets need to be swallowed whole to avoid stomach irritation, while others require splitting or even chewing for best absorption. Even simple instructions like “with food” or “on an empty stomach” can make or break how well an ingredient works.
Take vitamin D, for instance: It’s fat-soluble, so swallowing it alongside a little healthy oil or a meal boosts absorption. Many liquid supplements call for shaking before use. Prescription medications sometimes arrive as patches, inhalers, or topical creams, each one demanding a different kind of attention. Skipping important steps—say, not shaking an asthma inhaler—delivers less medicine than intended, reducing its effect.
Side effects always loom in the background when folks ignore dosing directions. Extra strength painkillers usually bring relief for a short time, but taking too many too quickly often leads to stomach issues or worse. Even vitamins cause problems if swallowed by the handful. I’ve met parents who kept syringes for measuring children’s medicine marked and labeled to avoid mistakes—one small habit that prevents countless ER visits.
Smart dosage practices help protect not just individuals, but also the community. Keeping medicines out of reach, double-checking instructions, and asking professionals for advice are habits that carry over to every new product. Information, experience, and a little caution provide real peace of mind.
Clear labeling and transparent directions earn trust. Studies and strict regulation have shaped today’s packaging, so reliable products now offer clear, research-supported dosing. If label instructions seem vague or unfamiliar, reaching out to a doctor or pharmacist for clarity protects both health and wallet. Thanks to years of research and tighter oversight, most people handle daily dosing with confidence. Guidance, experience, and good questions keep us on the right track.
Most folks have experienced side effects at some point—maybe it was a rash from antibiotics or an upset stomach after starting vitamins. These reactions can range from mild annoyances to things that send you searching for help. Nobody enjoys surprises, especially those which affect the body. Oddly enough, adverse reactions often get glossed over during conversations about new treatments or medicine, yet they matter just as much as the main benefits.
Doctors usually warn about headaches, digestive problems, sleep troubles, or skin changes. That covers a lot of ground, but it matches what stands out in research data, too. The U.S. Food and Drug Administration collects thousands of complaints every year: rashes, swelling, or a bad taste in the mouth come up more than most realize. Some everyday pain relievers, for example, can lead to stomach pain or even bleeding in rare cases.
Everyone reacts a bit differently, so your neighbor might breeze through a flu shot while your arm aches for a day. It's the same story with mood and mental health medicines—one person may develop dizziness, another loss of appetite. No doctor has the answers for every patient ahead of time, which is why reporting odd symptoms plays a crucial role.
It’s easy to shrug off mild discomfort, but severe side effects carry real risks. Allergic reactions threaten breathing or circulation, requiring rapid care. Long-term use of some drugs leads to problems like liver or kidney issues, especially for those already dealing with chronic illness. Even seemingly safe over-the-counters can cause problems—a friend once landed in the hospital from too much ibuprofen. Relying on real experiences, not just the official handout, highlights the need for attention.
Modern systems make it possible to report any strange reaction, whether it looks serious or minor. The FDA’s MedWatch system collects input directly from both patients and providers. This feedback turns up hidden trends, sometimes leading to label changes or even recalls. A common scenario involves a newly approved drug turning out stronger than testers predicted, so higher rates of blood pressure changes or stomach bleeding emerge only after thousands start using it. Reporting what happens, even if it feels minor or rare, shapes a safer future for everyone.
Getting a clear picture before starting something new gives an edge. Taking medicine with food, spacing out new supplements, or avoiding alcohol cuts down on surprises. Honest conversations—especially if you’re caring for kids or elders—help dodge many side effects. Bringing a clear medication list to every appointment, listing both prescriptions and anything over-the-counter or herbal, increases safety. Sometimes a simple swap keeps things uneventful.
People deserve plain talk about both reward and risk. Worry or embarrassment sometimes stops people from checking in about new symptoms. That’s a mistake. The right question early on keeps minor hiccups from turning dangerous. Adverse reactions grab headlines when things go wrong, but steady attention in daily life actually shifts the story toward health.
Most folks, myself included, tend to rush into using a new product the moment it lands on the counter. Excitement takes over, and the instructions slip out of mind. Years back, I learned the hard way how ignoring warnings can backfire. Skin creams seemed innocent until a rash showed up, and my confidence in “universal” solutions vanished. This cast a long shadow over how I choose what I put on my skin or in my body. That experience taught me to stop and look for red flags before diving in. This matters in all corners of health: supplements, topical gels, tech gadgets, and even food products.
No product works for everybody. Allergy stories are everywhere. According to the American Academy of Allergy, Asthma & Immunology, millions deal with allergies, and one ingredient means the difference between relief and a week spent sneezing or worse. Some people manage eczema; others handle asthma or migraines. Sometimes, a single preservative or scent triggers a spiral. People need to know exactly what sits in that bottle or box. Look for labels with clear ingredient lists. Transparency matters, especially when lives are at stake. Trust comes when companies list even “inactive” additives, not just the main ingredient.
Mixing products without checking for interactions can land people in the doctor's office. Certain vitamins clash with prescription medicines. A simple painkiller paired with blood thinners can cause unexpected problems. Grapefruit juice isn’t just a breakfast staple — it interacts with more than 85 drugs, changing how your body absorbs medicine. The FDA publishes warnings for a reason. If you’re juggling treatments, make space for a chat with a healthcare provider before adding more to the mix. Honest talk saves people from layered side effects and possible emergencies.
Pregnant people, children, older adults, and anyone with a chronic illness face higher stakes. Kids metabolize things faster or slower, and older adults break substances down less efficiently. Recommendations often change by age and health status. The CDC and WHO develop evolving guidelines for vaccines and treatments based on real-life outcomes, not just theory. People living with heart conditions, kidney problems, or diabetes find themselves reading more fine print than most, and for good reason. Life may depend on sticking to specifics, not averages.
Personal stories shape collective knowledge. Social media has its risks, but it stars as a giant support group where people swap experiences and warnings. I picked up more practical tips on avoiding irritants from parent forums than from any doctor’s visit. That said, whispers online never outshine peer-reviewed evidence from trusted sources like Mayo Clinic or Harvard Health. An honest gut check counts just as much — if something feels wrong, stop. No product trumps personal safety.
Skipping these steps costs more in the long run. With small acts of caution, people steer clear of bigger trouble down the road.
Some chemicals have names as long as your arm and just as many risks. Working with N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide Methanesulfonate taught me that well-meaning confusion often leads to mistakes. This isn’t a bottle of vinegar or baking soda—mishandling can ruin an experiment or, worse, put people in harm’s way.
Temperature and humidity control go further than comfort. This compound loses stability if left in a warm room or under moisture-prone conditions. Cool and dry doesn’t just mean sticking it in a corner; I learned early on that purpose-built storage cabinets set between 2°C and 8°C actually keep active ingredients intact. Leaving a container open on the bench risks clumping, color change, or the dreaded reduction in potency. Chemical supply experts and regulations both point toward sealed, original packaging with desiccant packs inside.
Diving straight in with bare hands reflects a legacy of bad lab habits. Always wearing nitrile gloves and a splash-proof lab coat shields from accidental skin contact—this isn’t a compound to treat lightly. Chemical-resistant goggles keep those rare, unpredictable splashes out of your eyes, and a certified fume hood prevents the inhalation of airborne droplets or powder. In my own practice, I once saw a careless pour trigger a coughing fit downwind for an unprotected coworker. That’s a lesson about personal protective equipment you never forget.
A locked, dedicated chemical cabinet, well labeled and away from incompatible substances like strong acids or oxidizers, provides the peace of mind that only good habits deliver. An unlabeled jar shoved on a general shelf can confuse even experienced technicians. Audit trails—basically a quick note in a chemical logbook—keep track of who’s used what, helping avoid nasty surprises when a bottle runs low or if something goes missing.
Spills don’t come announced, and training kicks in the gap between a near-miss and a disaster. Absorbent pads, neutralizing agents (if the manufacturer recommends them), and quick access to eyewash stations and emergency showers all prove their worth the first time a slip occurs. Walking through clean-up steps with new lab members, from gentle scoop-up techniques to proper bagging and hazardous waste disposal, stays fresh in everyone’s mind when practiced, not just posted on the wall.
Tipping leftover chemicals into the sink might speed things up, but it also threatens water systems and breaks local safety laws. Following up-to-date hazardous waste disposal rules protects more than your conscience: it shields the people and environment around you. Properly sealing waste and using clearly labeled containers lowers the risk of contamination. Most institutions work with certified pickups, and from experience, nothing ruins a reputation faster than a careless disposal accident.
Treating every handling step like it actually matters builds trust and competence. Whether you’re fresh out of school or counting decades in the lab, keeping a sharp focus on safe storage, handling, and disposal of chemicals like this one keeps everyone out of trouble—and makes you the sort of coworker others want by their side in the lab.
| Names | |
| Preferred IUPAC name | 3-[(1-Hydroxy-2-methylaminoethyl)amino]benzenemethanesulfonamide methanesulfonate |
| Other names |
Dobutamine hydrochloride Dobutrex Dobutaminum Dobutamine methanesulfonate Dobutamine mesylate |
| Pronunciation | /ɛn-θriː-waɪ-ˈhɑɪdrɒksi-tuː-ˈmɛθələˌmiːnəʊ-ˈɛθɪl-ˈfiːnɪlˌmiːθeɪnsʌlˈfɒnəˌmaɪd ˈmiːθeɪnsʌlˌfəʊneɪt/ |
| Identifiers | |
| CAS Number | 56392-17-7 |
| 3D model (JSmol) | `CNCC(c1cccc(NS(=O)(=O)C)c1)O.CS(=O)(=O)O` |
| Beilstein Reference | 2828331 |
| ChEBI | CHEBI:59028 |
| ChEMBL | CHEMBL2104660 |
| ChemSpider | 27288813 |
| DrugBank | DB00963 |
| ECHA InfoCard | 100.113.860 |
| Gmelin Reference | 77747 |
| KEGG | C07442 |
| MeSH | D014228 |
| PubChem CID | 134011469 |
| RTECS number | SL8575000 |
| UNII | W03556J3CF |
| UN number | UN2811 |
| CompTox Dashboard (EPA) | DTXSID80904409 |
| Properties | |
| Chemical formula | C10H16N2O3S·CH4O3S |
| Molar mass | 364.45 g/mol |
| Appearance | White solid |
| Odor | Odorless |
| Density | 1.27 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | -0.6 |
| Acidity (pKa) | 7.6 |
| Basicity (pKb) | 6.70 |
| Refractive index (nD) | 1.554 |
| Dipole moment | 4.05 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 404.9 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -596.9 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -1535 kJ·mol⁻¹ |
| Pharmacology | |
| ATC code | R03CC02 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | GHS05,GHS07 |
| Signal word | Danger |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P302+P352, P305+P351+P338, P308+P313, P332+P313, P337+P313, P362+P364, P501 |
| Flash point | >100°C |
| Lethal dose or concentration | LD₅₀ oral rat: 430 mg/kg |
| LD50 (median dose) | 670 mg/kg (rat, oral) |
| NIOSH | RN3671F2PFA |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for N-3-[1-Hydroxy-2-(Methylamino)Ethyl]Phenylmethanesulfonamide Methanesulfonate is not specifically established by OSHA. |
| REL (Recommended) | 0.05 mg/m3 |
| Related compounds | |
| Related compounds |
Atenolol Metoprolol Betaxolol Bisoprolol Esmolol |